Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

PSYC US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Telemynd, Inc.(PSYC US)

$0.00+0.000.00%(Market Open · 21:00:00 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

PSYC US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Telemynd, Inc.(PSYC US)

$0.00+0.000.00%(Market Open · 21:00:00 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Telemynd, Inc. — Company Profile

PSYC Corporation operates as a media company focuses on psychedelic and cannabis sectors. It owns and operates Psychedelic Spotlight, a media platform for news, information, and content for all things psychedelic-related. The company was formerly known as Global Trac Solutions, Inc. and changed its name to PSYC Corporation in February 2022. PSYC Corporation is based in Las Vegas, Nevada.

Sector
Communication Services
Industry
Advertising Agencies
Exchange
UU
CEO
Daniel Jaros
Headquarters
Las Vegas, MA, US
IPO Date
Jun 15, 2010
Employees
2
Website
www.psyccorporation.com

Key Metrics

Price
$0.00
Market Cap
$187.22K
Revenue (TTM)
$21.00
Net Income (TTM)
$-1277175.00
EPS (TTM)
-0.00
P/E (TTM)
-0.15
P/B (TTM)
-0.02
Dividend Yield
0.00%
ROE (TTM)
11.12%
ROA (TTM)
-180.58%
Operating Margin
-7284.00%
Beta
-209.99

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

PSYC Corporation operates as a media company focuses on psychedelic and cannabis sectors. It owns and operates Psychedelic Spotlight, a media platform for news, information, and content for all things psychedelic-related. The company was formerly known as Global Trac Solutions, Inc. and changed its name to PSYC Corporation in February 2022. PSYC Corporation is based in Las Vegas, Nevada.

Website
www.psyccorporation.com
Location
Las Vegas, MA, US
Phone619-564-7811
Employees2
CEODaniel Jaros
Sector
Communication Services
IndustryAdvertising Agencies
IPO DateJun 15, 2010

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(35)

Expand
  • D/A06b16 Dec 2022
  • D06b15 Dec 2022
  • 15-12GNotice of suspension of duty to file15 Nov 2019
  • RWREGISTRATION WITHDRAWAL REQUEST15 Nov 2019
  • 8-KEntry into Material Agreement6 Nov 2019
  • 8-KExit or Disposal Activity Costs24 Oct 2019
  • S-1/AAMENDMENT NO.3 TO REGISTRATION STATEMENT3 Oct 2019
  • S-1/AAMENDMENT NO. 2 TO REGISTRATION STATEMENT17 Sep 2019
  • S-1/AAMENDMENT NO. 1 TO FORM S-19 Sep 2019
  • SC 13GTelemynd, Inc.26 Aug 2019
  • 10-QQ3ended 30 Jun 201914 Aug 2019
  • S-1Registration statement (general form)23 Jul 2019
  • 8-KDirector/Officer Changes & Compensatory Arrangements19 Jul 2019
  • Form 4Unanue Peter18 Jul 2019
  • Form 4PAPPAJOHN JOHN18 Jul 2019
  • Form 4Harris Geoffrey E.18 Jul 2019
  • Form 4D'Ambrosio Donald Eric18 Jul 2019
  • Form 3Unanue Peter5 Jul 2019
  • Form 3PAPPAJOHN JOHN5 Jul 2019
  • Form 3Harris Geoffrey E.5 Jul 2019

Key Stats

Trading

Px/Chg 1D$0.00 / +0.00%
Avg Volume17.01M
Beta-209.99
Mkt Cap187.22K
FD Mkt Cap187.22K

Float

Shrs Out/Float1.87B / 760.70M
Short Float0.00%
Days to Cover1.00
Stock Repurchased$0.00

Current Valuation

EV7.20M
EV/EBITDA-12.36
EV/Sales342,939.43
P/B-0.02
P/S8,915.14
FCF Yield-713.79%
ROE11.12%
ROA-180.58%
Current Ratio0.04

Estimates

P/E-0.15
Est P/E0.00
Est EPS0.00
Est PEG0.00

Valuation

Metric5Yr AvgDec '21Jun '22Mar '23Mar '24Oct '26
PRICE-BASED RATIOS
Price / Earnings-0.55-0.22-0.85-0.92-0.63-0.15
Price / Sales1,799.500.0057.4720.674.218,915.14
Price / Book Value-0.14-0.13-0.20-0.27-0.08-0.02
Price / Free Cash Flow-1.23-0.94-2.05-1.86-1.19-0.14
ENTERPRISE VALUE METRICS
Enterprise Value7.35.56.88.98.07.2
Enterprise Value / Sales68,657.070.00235.3671.3539.24342,939.43
Enterprise Value / EBITDA-7.42-1.61-7.32-4.49-11.32-12.36
Enterprise Value / EBIT-7.40-1.60-7.29-4.49-11.24-12.35

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '20Dec '21Dec '22Dec '23Dec '24
INCOME STATEMENT
Revenue—-0.00.10.20.0
Gross Income-51.4%-0.00.00.10.2-0.0
EBITDA-35.6%-3.4-0.9-2.0-0.7-0.6
EBIT-35.7%-3.4-0.9-2.0-0.7-0.6
Net Income-26.6%-4.4-2.0-2.8-1.4-1.3
EPS (Diluted)-54.4%-0.03-0.00-0.01-0.00-0.00
BALANCE SHEET
Cash & ST Inv-43.8%0.20.10.20.10.0
Total Assets35.6%0.20.20.51.10.7
Total Liabilities13.1%7.58.4100.011.512.2
Total Shareholder Equity12.2%-7.2-8.2-9.6-10.4-11.5
CASH FLOW
Net Operating Cash Flow7%-1.0-0.8-1.4-0.7-1.3
Cap Ex-5.4%-0.0-0.0-0.0-0.0
Free Cash Flow7%-1.0-0.8-1.4-0.7-1.3

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)0.00
Basic Shares1,872.18
Market Cap0.2
Diluted Shares979.99
Fully Diluted Shares Outstanding979.99
Fully Diluted Market Cap0.1
+Consolidated Debt7.0
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-0.0
−Short-term Investments-
+Total Preferred0.1
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value7.2

Related companies

Fresenius Medical Care AG

FMS US

Davita Inc.

DVA US

Park Dental Partners, Inc.

PARK US

Cryo Cell International Inc

CCEL US

Pacific Health Care Organization Inc

PFHO US

Mangoceuticals, Inc.

MGRX US

BioRestorative Therapies, Inc.

BRTX US

NewGenIvf Group Ltd

NIVF US

Ontrak, Inc.

OTRKQ US

AnTix Holdings, Inc.

IMTH US

American Renal Associates Holdings, Inc.

ARA B1

Telemynd, Inc. — Company Profile

PSYC Corporation operates as a media company focuses on psychedelic and cannabis sectors. It owns and operates Psychedelic Spotlight, a media platform for news, information, and content for all things psychedelic-related. The company was formerly known as Global Trac Solutions, Inc. and changed its name to PSYC Corporation in February 2022. PSYC Corporation is based in Las Vegas, Nevada.

Sector
Communication Services
Industry
Advertising Agencies
Exchange
UU
CEO
Daniel Jaros
Headquarters
Las Vegas, MA, US
IPO Date
Jun 15, 2010
Employees
2
Website
www.psyccorporation.com

Key Metrics

Price
$0.00
Market Cap
$187.22K
Revenue (TTM)
$21.00
Net Income (TTM)
$-1277175.00
EPS (TTM)
-0.00
P/E (TTM)
-0.15
P/B (TTM)
-0.02
Dividend Yield
0.00%
ROE (TTM)
11.12%
ROA (TTM)
-180.58%
Operating Margin
-7284.00%
Beta
-209.99

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

PSYC Corporation operates as a media company focuses on psychedelic and cannabis sectors. It owns and operates Psychedelic Spotlight, a media platform for news, information, and content for all things psychedelic-related. The company was formerly known as Global Trac Solutions, Inc. and changed its name to PSYC Corporation in February 2022. PSYC Corporation is based in Las Vegas, Nevada.

Website
www.psyccorporation.com
Location
Las Vegas, MA, US
Phone619-564-7811
Employees2
CEODaniel Jaros
Sector
Communication Services
IndustryAdvertising Agencies
IPO DateJun 15, 2010

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(35)

Expand
  • D/A06b16 Dec 2022
  • D06b15 Dec 2022
  • 15-12GNotice of suspension of duty to file15 Nov 2019
  • RWREGISTRATION WITHDRAWAL REQUEST15 Nov 2019
  • 8-KEntry into Material Agreement6 Nov 2019
  • 8-KExit or Disposal Activity Costs24 Oct 2019
  • S-1/AAMENDMENT NO.3 TO REGISTRATION STATEMENT3 Oct 2019
  • S-1/AAMENDMENT NO. 2 TO REGISTRATION STATEMENT17 Sep 2019
  • S-1/AAMENDMENT NO. 1 TO FORM S-19 Sep 2019
  • SC 13GTelemynd, Inc.26 Aug 2019
  • 10-QQ3ended 30 Jun 201914 Aug 2019
  • S-1Registration statement (general form)23 Jul 2019
  • 8-KDirector/Officer Changes & Compensatory Arrangements19 Jul 2019
  • Form 4Unanue Peter18 Jul 2019
  • Form 4PAPPAJOHN JOHN18 Jul 2019
  • Form 4Harris Geoffrey E.18 Jul 2019
  • Form 4D'Ambrosio Donald Eric18 Jul 2019
  • Form 3Unanue Peter5 Jul 2019
  • Form 3PAPPAJOHN JOHN5 Jul 2019
  • Form 3Harris Geoffrey E.5 Jul 2019

Key Stats

Trading

Px/Chg 1D$0.00 / +0.00%
Avg Volume17.01M
Beta-209.99
Mkt Cap187.22K
FD Mkt Cap187.22K

Float

Shrs Out/Float1.87B / 760.70M
Short Float0.00%
Days to Cover1.00
Stock Repurchased$0.00

Current Valuation

EV7.20M
EV/EBITDA-12.36
EV/Sales342,939.43
P/B-0.02
P/S8,915.14
FCF Yield-713.79%
ROE11.12%
ROA-180.58%
Current Ratio0.04

Estimates

P/E-0.15
Est P/E0.00
Est EPS0.00
Est PEG0.00

Valuation

Metric5Yr AvgDec '21Jun '22Mar '23Mar '24Oct '26
PRICE-BASED RATIOS
Price / Earnings-0.55-0.22-0.85-0.92-0.63-0.15
Price / Sales1,799.500.0057.4720.674.218,915.14
Price / Book Value-0.14-0.13-0.20-0.27-0.08-0.02
Price / Free Cash Flow-1.23-0.94-2.05-1.86-1.19-0.14
ENTERPRISE VALUE METRICS
Enterprise Value7.35.56.88.98.07.2
Enterprise Value / Sales68,657.070.00235.3671.3539.24342,939.43
Enterprise Value / EBITDA-7.42-1.61-7.32-4.49-11.32-12.36
Enterprise Value / EBIT-7.40-1.60-7.29-4.49-11.24-12.35

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '20Dec '21Dec '22Dec '23Dec '24
INCOME STATEMENT
Revenue—-0.00.10.20.0
Gross Income-51.4%-0.00.00.10.2-0.0
EBITDA-35.6%-3.4-0.9-2.0-0.7-0.6
EBIT-35.7%-3.4-0.9-2.0-0.7-0.6
Net Income-26.6%-4.4-2.0-2.8-1.4-1.3
EPS (Diluted)-54.4%-0.03-0.00-0.01-0.00-0.00
BALANCE SHEET
Cash & ST Inv-43.8%0.20.10.20.10.0
Total Assets35.6%0.20.20.51.10.7
Total Liabilities13.1%7.58.4100.011.512.2
Total Shareholder Equity12.2%-7.2-8.2-9.6-10.4-11.5
CASH FLOW
Net Operating Cash Flow7%-1.0-0.8-1.4-0.7-1.3
Cap Ex-5.4%-0.0-0.0-0.0-0.0
Free Cash Flow7%-1.0-0.8-1.4-0.7-1.3

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)0.00
Basic Shares1,872.18
Market Cap0.2
Diluted Shares979.99
Fully Diluted Shares Outstanding979.99
Fully Diluted Market Cap0.1
+Consolidated Debt7.0
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-0.0
−Short-term Investments-
+Total Preferred0.1
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value7.2

Related companies

Fresenius Medical Care AG

FMS US

Davita Inc.

DVA US

Park Dental Partners, Inc.

PARK US

Cryo Cell International Inc

CCEL US

Pacific Health Care Organization Inc

PFHO US

Mangoceuticals, Inc.

MGRX US

BioRestorative Therapies, Inc.

BRTX US

NewGenIvf Group Ltd

NIVF US

Ontrak, Inc.

OTRKQ US

AnTix Holdings, Inc.

IMTH US

American Renal Associates Holdings, Inc.

ARA B1